MHC-based diagnostics and therapeutics - clinical applications for disease-linked genes.
Howard
M C
MC
Corixa Corporation (formerly Anergen Inc.), Redwood City, CA, USA.
Spack
E G
EG
Choudhury
K
K
Greten
T F
TF
Schneck
J P
JP
D000818:Animals; D001327:Autoimmune Diseases / Q000628:therapy; D015683:Gene Products, gag / Q000378:metabolism; D016356:Gene Products, tax / Q000378:metabolism; D015789:HLA-A2 Antigen; D006649:Histocompatibility Antigens / Q000627:therapeutic use*; D015368:Human T-lymphotropic virus 1; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D007167:Immunotherapy / Q000639:trends*; D008285:Major Histocompatibility Complex / Q000276:immunology*; D051379:Mice; D015493:Paraparesis, Tropical Spastic / Q000175:diagnosis / Q000821:virology; D013601:T-Lymphocytes / Q000276:immunology
D015683:Gene Products, gag; D016356:Gene Products, tax; D015789:HLA-A2 Antigen; D006649:Histocompatibility Antigens; D007074:Immunoglobulin G